ART Provider and Patient Resource to Improve Communication about Outcomes and Treatment (APRICOT)

Information

  • Research Project
  • 10384472
  • ApplicationId
    10384472
  • Core Project Number
    R43DP006690
  • Full Project Number
    1R43DP006690-01
  • Serial Number
    006690
  • FOA Number
    PA-20-260
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 3 years ago
  • Project End Date
    9/29/2022 - 2 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/2021 - 3 years ago
  • Budget End Date
    9/29/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/13/2021 - 3 years ago

ART Provider and Patient Resource to Improve Communication about Outcomes and Treatment (APRICOT)

Project Summary/Abstract Infertility affects an estimated 8-12% of reproductive-aged couples, leading many to seek assisted reproductive technologies (ART) treatments such as in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). Approximately 1.9% of infants born in the United States each year are conceived using ART. The Fertility Clinic Success Rate and Certification Act (FCSRCA) of 1992 mandates that clinics performing ART treatment annually report success rate data to the Centers for Disease Control and Prevention (CDC); however, clinics face challenges in collecting accurate pregnancy outcome information from these patients or the patients' new healthcare providers. To collect pregnancy outcomes, ART clinics rely on traditional outreach methods, including telephone, mail, and email, to obtain information from patients, who may be out of state or even country, and their obstetric providers. This process requires significant effort, often requiring multiple attempts. However, collecting this information is important because the CDC uses ART surveillance data to monitor the success rates of treatments performed in the U.S. and to characterize the short- and long-term health effects of ART on patients and infants conceived after ART treatments. To improve the response rates and data quality while reducing per patient costs, Charles River Analytics and our collaborator, Dr. Shruthi Mahalingaiah from Massachusetts General Hospital, propose to design and evaluate an ART Provider and Patient Resource to Improve Communication about Outcomes and Treatment (APRICOT). APRICOT is a health information technology (HIT) application to alleviate the burden on assisted reproductive technology (ART) clinics associated with collecting pregnancy outcomes from prior ART patients and the patients' other healthcare providers. Under this Phase I effort, we will use human factors engineering methods, including qualitative research methods, contextual design, and user acceptance testing, to elicit clinic and patient user requirements, design candidate workflows and user interfaces, and demonstrate the feasibility of developing APRICOT. Our effort will establish ART clinic and patient user requirements and produce conceptual designs for a pregnancy outcome reporting platform that facilitates streamlined communication between ART clinics and their patients. APRICOT will enable fertility clinics to collect pregnancy outcome information efficiently and effectively from prior ART patients and the patients' other healthcare providers. APRICOT will assist clinics in meeting federally mandated reporting requirements by reducing the effort required of clinic staff to collect pregnancy outcome information from previous ART patients and their obstetric providers, helping clinics to realize time and monetary cost savings in collecting pregnancy outcomes from prior patients.

IC Name
NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO
  • Activity
    R43
  • Administering IC
    DP
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    243459
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    103
  • Ed Inst. Type
  • Funding ICs
    NCCDPHP:12547\ODCDC:230912\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CHARLES RIVER ANALYTICS, INC.
  • Organization Department
  • Organization DUNS
    115243701
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021384555
  • Organization District
    UNITED STATES